ORAL SCOPOLAMINE ANTIEMETIC EFFICACY VERSUS PLACEBO
This article was originally published in The Tan Sheet
Executive Summary
ORAL SCOPOLAMINE ANTIEMETIC EFFICACY VERSUS PLACEBO is supported by a recent clinical study by SeaTone and Upjohn submitted to FDA May 25, according to the study investigator. "Overall, the study is supportive to the efficacy of oral scopolamine with significant differences being found in subjects' final assessment of treatment effectiveness," the study report concludes.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning